Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Sucampo Pharmaceuticals, Inc.

    Client Virtual Booth

    SUCAMPO PHARMACEUTICALS, INC.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Sucampo Pharmaceuticals, Inc.
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    --
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.sucampo.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    left grey arrow
    right gray arrow
    Full View ScreenFull Screen View
    Leaving Cerecor after a year, Peter Greenleaf starts a new CEO chapter
    Leaving Cerecor after a year, Peter Greenleaf starts a new CEO chapter

    https://endpts.com/peer-review-leaving-cerecor-after-a-year-peter-greenleaf-starts-a-new-ceo-chapter-at-aurinia-out-to-slay-restasis/

    Amber Tong ENDPTS
    12 Apr 2019
    Share Share
    Prezista (darunavir) : Janssen Sc. Ireland vs. Amneal Pharma
    Prezista (darunavir) : Janssen Sc. Ireland vs. Amneal Pharma

    https://insight.rpxcorp.com/litigation_documents/13186036

    PATENT LITIGATION
    20 Dec 2018
    Share Share
    Mallinckrodt spinoff to include 7 manufacturing sites in U.S. and Japan
    Mallinckrodt spinoff to include 7 manufacturing sites in U.S. and Japan

    https://www.fiercepharma.com/manufacturing/mallinckrodt-spinoff-to-include-seven-manufacturing-sites-u-s-and-japan

    Eric Palmer FIERCE PHARMA
    19 Dec 2018
    Share Share
    Prolensa (Bromfenac) : Senju Pharmaceutical, B&L vs. Amneal Pharmaceuticals
    Prolensa (Bromfenac) : Senju Pharmaceutical, B&L vs. Amneal Pharmaceuticals

    https://insight.rpxcorp.com/litigation_documents/13168076

    PATENT LITIGATION
    10 Dec 2018
    Share Share
    Mallinckrodt to spin off generics business, but to keep options open
    Mallinckrodt to spin off generics business, but to keep options open

    https://www.reuters.com/article/us-mallinckrodt-spinoff/mallinckrodt-to-spin-off-generics-business-but-to-keep-options-open-idUSKBN1O516U

    Saumya Joseph REUTERS
    06 Dec 2018
    Share Share
    AMITIZA® (lubiprostone) : Sucampo Pharmaceuticals vs. Sun Pharmaceutical
    AMITIZA® (lubiprostone) : Sucampo Pharmaceuticals vs. Sun Pharmaceutical

    https://www.pharmacompass.com/pdf/news/amitiza-lubiprostone-sucampo-pharmaceuticals-vs-sun-pharmaceutical-1543986787.pdf

    PATENT LITIGATION
    31 Oct 2018
    Share Share
    After 3 years of hunting a buyer, Trulance maker Synergy desperate for cash
    After 3 years of hunting a buyer, Trulance maker Synergy desperate for cash

    https://www.fiercepharma.com/pharma/3-5-years-and-no-deal-bruised-trulance-maker-synergy-desperate-for-new-funding

    Angus Liu FIERCE PHARMA
    26 Oct 2018
    Share Share
    Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.
    Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.

    https://www.prnewswire.com/news-releases/mallinckrodt-completes-acquisition-of-sucampo-pharmaceuticals-inc-300597907.html

    PR NEWSWIRE
    13 Feb 2018
    Share Share
    Mallinckrodt pays $1.2bn for Sucampo Pharma
    Mallinckrodt pays $1.2bn for Sucampo Pharma

    http://www.pmlive.com/pharma_news/mallinckrodt_pays_$1.2bn_for_sucampo_pharma_1215000

    Phil Taylor PMLIVE
    03 Jan 2018
    Share Share
    Deal spree, Mallinckrodt bags Sucampo & two late-stage rare disease drugs $1.2B
    Deal spree, Mallinckrodt bags Sucampo & two late-stage rare disease drugs $1.2B

    https://endpts.com/on-a-deal-spree-mallinckrodt-bags-sucampo-and-2-late-stage-rare-disease-drugs-for-1-2b/

    John Carroll ENDPTS
    27 Dec 2017
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-05-06

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search